nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7—Simvastatin—atherosclerosis	0.0588	0.0791	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0588	0.0791	CbGbCtD
Triazolam—CYP3A7—Lovastatin—atherosclerosis	0.0576	0.0774	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0576	0.0774	CbGbCtD
Triazolam—CYP3A5—Rosuvastatin—atherosclerosis	0.0475	0.0638	CbGbCtD
Triazolam—CYP3A5—Simvastatin—atherosclerosis	0.0441	0.0594	CbGbCtD
Triazolam—CYP3A5—Pravastatin—atherosclerosis	0.0432	0.0581	CbGbCtD
Triazolam—CYP3A5—Lovastatin—atherosclerosis	0.0432	0.0581	CbGbCtD
Triazolam—CYP2C8—Simvastatin—atherosclerosis	0.0424	0.0571	CbGbCtD
Triazolam—CYP2C8—Lovastatin—atherosclerosis	0.0415	0.0558	CbGbCtD
Triazolam—CYP2C8—Pravastatin—atherosclerosis	0.0415	0.0558	CbGbCtD
Triazolam—CYP2C9—Rosuvastatin—atherosclerosis	0.0318	0.0428	CbGbCtD
Triazolam—CYP2C9—Simvastatin—atherosclerosis	0.0296	0.0398	CbGbCtD
Triazolam—CYP2C9—Lovastatin—atherosclerosis	0.029	0.039	CbGbCtD
Triazolam—CYP2C9—Pravastatin—atherosclerosis	0.029	0.039	CbGbCtD
Triazolam—CYP3A4—Rosuvastatin—atherosclerosis	0.0185	0.0249	CbGbCtD
Triazolam—CYP3A4—Ezetimibe—atherosclerosis	0.0185	0.0249	CbGbCtD
Triazolam—CYP3A4—Simvastatin—atherosclerosis	0.0172	0.0231	CbGbCtD
Triazolam—CYP3A4—Pravastatin—atherosclerosis	0.0168	0.0226	CbGbCtD
Triazolam—CYP3A4—Lovastatin—atherosclerosis	0.0168	0.0226	CbGbCtD
Triazolam—Sleep disturbance—Simvastatin—atherosclerosis	0.0035	0.0172	CcSEcCtD
Triazolam—Sexual dysfunction—Simvastatin—atherosclerosis	0.0035	0.0172	CcSEcCtD
Triazolam—Sleep disturbance—Pravastatin—atherosclerosis	0.00316	0.0156	CcSEcCtD
Triazolam—Sexual dysfunction—Pravastatin—atherosclerosis	0.00316	0.0156	CcSEcCtD
Triazolam—Memory impairment—Rosuvastatin—atherosclerosis	0.00315	0.0155	CcSEcCtD
Triazolam—Respiratory tract infection—Pravastatin—atherosclerosis	0.00282	0.0139	CcSEcCtD
Triazolam—Memory impairment—Lovastatin—atherosclerosis	0.00267	0.0131	CcSEcCtD
Triazolam—Redness—Niacin—atherosclerosis	0.00267	0.0131	CcSEcCtD
Triazolam—Memory impairment—Ezetimibe—atherosclerosis	0.00262	0.0129	CcSEcCtD
Triazolam—Memory impairment—Simvastatin—atherosclerosis	0.0025	0.0123	CcSEcCtD
Triazolam—Eye irritation—Lovastatin—atherosclerosis	0.00245	0.0121	CcSEcCtD
Triazolam—Nightmare—Rosuvastatin—atherosclerosis	0.00239	0.0118	CcSEcCtD
Triazolam—Memory impairment—Pravastatin—atherosclerosis	0.00226	0.0111	CcSEcCtD
Triazolam—Sleep disorder—Rosuvastatin—atherosclerosis	0.00207	0.0102	CcSEcCtD
Triazolam—Hepatic failure—Rosuvastatin—atherosclerosis	0.002	0.00983	CcSEcCtD
Triazolam—Amnesia—Rosuvastatin—atherosclerosis	0.00191	0.0094	CcSEcCtD
Triazolam—Nightmare—Simvastatin—atherosclerosis	0.00189	0.00931	CcSEcCtD
Triazolam—Hearing impaired—Pravastatin—atherosclerosis	0.00186	0.00916	CcSEcCtD
Triazolam—Nightmare—Pravastatin—atherosclerosis	0.00171	0.00842	CcSEcCtD
Triazolam—Hepatic failure—Lovastatin—atherosclerosis	0.00169	0.00833	CcSEcCtD
Triazolam—Hepatic failure—Ezetimibe—atherosclerosis	0.00166	0.00817	CcSEcCtD
Triazolam—Sleep disorder—Simvastatin—atherosclerosis	0.00164	0.00809	CcSEcCtD
Triazolam—Amnesia—Lovastatin—atherosclerosis	0.00162	0.00797	CcSEcCtD
Triazolam—Amnesia—Ezetimibe—atherosclerosis	0.00159	0.00782	CcSEcCtD
Triazolam—Hepatic failure—Simvastatin—atherosclerosis	0.00158	0.00779	CcSEcCtD
Triazolam—Muscular weakness—Rosuvastatin—atherosclerosis	0.00158	0.00779	CcSEcCtD
Triazolam—Amnesia—Simvastatin—atherosclerosis	0.00151	0.00745	CcSEcCtD
Triazolam—Sleep disorder—Pravastatin—atherosclerosis	0.00149	0.00731	CcSEcCtD
Triazolam—Deafness—Pravastatin—atherosclerosis	0.00144	0.00708	CcSEcCtD
Triazolam—Hepatic failure—Pravastatin—atherosclerosis	0.00143	0.00704	CcSEcCtD
Triazolam—Cramp muscle—Lovastatin—atherosclerosis	0.00137	0.00674	CcSEcCtD
Triazolam—Amnesia—Pravastatin—atherosclerosis	0.00137	0.00674	CcSEcCtD
Triazolam—Jaundice—Rosuvastatin—atherosclerosis	0.00135	0.00664	CcSEcCtD
Triazolam—Cramp muscle—Ezetimibe—atherosclerosis	0.00134	0.00661	CcSEcCtD
Triazolam—Muscular weakness—Ezetimibe—atherosclerosis	0.00132	0.00648	CcSEcCtD
Triazolam—Cramp muscle—Simvastatin—atherosclerosis	0.00128	0.00631	CcSEcCtD
Triazolam—Affect lability—Pravastatin—atherosclerosis	0.00127	0.00623	CcSEcCtD
Triazolam—Muscular weakness—Simvastatin—atherosclerosis	0.00125	0.00618	CcSEcCtD
Triazolam—Urinary retention—Niacin—atherosclerosis	0.00124	0.00611	CcSEcCtD
Triazolam—Mood swings—Pravastatin—atherosclerosis	0.00122	0.006	CcSEcCtD
Triazolam—Cramp muscle—Pravastatin—atherosclerosis	0.00116	0.0057	CcSEcCtD
Triazolam—Muscular weakness—Niacin—atherosclerosis	0.00115	0.00567	CcSEcCtD
Triazolam—Muscular weakness—Pravastatin—atherosclerosis	0.00113	0.00558	CcSEcCtD
Triazolam—Jaundice—Ezetimibe—atherosclerosis	0.00112	0.00552	CcSEcCtD
Triazolam—Sweating increased—Pravastatin—atherosclerosis	0.00108	0.00533	CcSEcCtD
Triazolam—Jaundice—Simvastatin—atherosclerosis	0.00107	0.00526	CcSEcCtD
Triazolam—Flatulence—Rosuvastatin—atherosclerosis	0.00107	0.00524	CcSEcCtD
Triazolam—Dysuria—Pravastatin—atherosclerosis	0.00104	0.00512	CcSEcCtD
Triazolam—Stomatitis—Niacin—atherosclerosis	0.000981	0.00483	CcSEcCtD
Triazolam—Jaundice—Niacin—atherosclerosis	0.000981	0.00483	CcSEcCtD
Triazolam—Jaundice—Pravastatin—atherosclerosis	0.000966	0.00476	CcSEcCtD
Triazolam—Flatulence—Lovastatin—atherosclerosis	0.000903	0.00444	CcSEcCtD
Triazolam—Erythema—Ezetimibe—atherosclerosis	0.000898	0.00442	CcSEcCtD
Triazolam—Dysgeusia—Lovastatin—atherosclerosis	0.000897	0.00441	CcSEcCtD
Triazolam—Confusional state—Rosuvastatin—atherosclerosis	0.000889	0.00438	CcSEcCtD
Triazolam—Flatulence—Ezetimibe—atherosclerosis	0.000885	0.00436	CcSEcCtD
Triazolam—Muscle spasms—Lovastatin—atherosclerosis	0.000881	0.00433	CcSEcCtD
Triazolam—Visual impairment—Niacin—atherosclerosis	0.000871	0.00429	CcSEcCtD
Triazolam—Muscle spasms—Ezetimibe—atherosclerosis	0.000864	0.00425	CcSEcCtD
Triazolam—Tremor—Lovastatin—atherosclerosis	0.000858	0.00422	CcSEcCtD
Triazolam—Visual impairment—Pravastatin—atherosclerosis	0.000858	0.00422	CcSEcCtD
Triazolam—Erythema—Simvastatin—atherosclerosis	0.000857	0.00422	CcSEcCtD
Triazolam—Ill-defined disorder—Lovastatin—atherosclerosis	0.00085	0.00418	CcSEcCtD
Triazolam—Flatulence—Simvastatin—atherosclerosis	0.000844	0.00416	CcSEcCtD
Triazolam—Tinnitus—Niacin—atherosclerosis	0.000843	0.00415	CcSEcCtD
Triazolam—Dysgeusia—Simvastatin—atherosclerosis	0.000839	0.00413	CcSEcCtD
Triazolam—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000834	0.0041	CcSEcCtD
Triazolam—Tinnitus—Pravastatin—atherosclerosis	0.00083	0.00408	CcSEcCtD
Triazolam—Malaise—Lovastatin—atherosclerosis	0.000826	0.00407	CcSEcCtD
Triazolam—Muscle spasms—Simvastatin—atherosclerosis	0.000824	0.00405	CcSEcCtD
Triazolam—Malaise—Ezetimibe—atherosclerosis	0.00081	0.00399	CcSEcCtD
Triazolam—Tremor—Simvastatin—atherosclerosis	0.000803	0.00395	CcSEcCtD
Triazolam—Insomnia—Rosuvastatin—atherosclerosis	0.000798	0.00393	CcSEcCtD
Triazolam—Ill-defined disorder—Simvastatin—atherosclerosis	0.000795	0.00391	CcSEcCtD
Triazolam—Palpitations—Ezetimibe—atherosclerosis	0.000794	0.00391	CcSEcCtD
Triazolam—Paraesthesia—Rosuvastatin—atherosclerosis	0.000792	0.0039	CcSEcCtD
Triazolam—Erythema—Niacin—atherosclerosis	0.000787	0.00387	CcSEcCtD
Triazolam—Chest pain—Lovastatin—atherosclerosis	0.00078	0.00384	CcSEcCtD
Triazolam—Anxiety—Lovastatin—atherosclerosis	0.000777	0.00382	CcSEcCtD
Triazolam—Hypertension—Ezetimibe—atherosclerosis	0.000776	0.00382	CcSEcCtD
Triazolam—Flatulence—Niacin—atherosclerosis	0.000775	0.00382	CcSEcCtD
Triazolam—Malaise—Simvastatin—atherosclerosis	0.000773	0.0038	CcSEcCtD
Triazolam—Tension—Niacin—atherosclerosis	0.000772	0.0038	CcSEcCtD
Triazolam—Discomfort—Lovastatin—atherosclerosis	0.000771	0.00379	CcSEcCtD
Triazolam—Chest pain—Ezetimibe—atherosclerosis	0.000765	0.00376	CcSEcCtD
Triazolam—Nervousness—Niacin—atherosclerosis	0.000764	0.00376	CcSEcCtD
Triazolam—Flatulence—Pravastatin—atherosclerosis	0.000763	0.00376	CcSEcCtD
Triazolam—Dry mouth—Lovastatin—atherosclerosis	0.000763	0.00375	CcSEcCtD
Triazolam—Tension—Pravastatin—atherosclerosis	0.00076	0.00374	CcSEcCtD
Triazolam—Dysgeusia—Pravastatin—atherosclerosis	0.000759	0.00373	CcSEcCtD
Triazolam—Muscle spasms—Niacin—atherosclerosis	0.000756	0.00372	CcSEcCtD
Triazolam—Discomfort—Ezetimibe—atherosclerosis	0.000756	0.00372	CcSEcCtD
Triazolam—Pain—Rosuvastatin—atherosclerosis	0.000754	0.00371	CcSEcCtD
Triazolam—Constipation—Rosuvastatin—atherosclerosis	0.000754	0.00371	CcSEcCtD
Triazolam—Confusional state—Lovastatin—atherosclerosis	0.000754	0.00371	CcSEcCtD
Triazolam—Nervousness—Pravastatin—atherosclerosis	0.000752	0.0037	CcSEcCtD
Triazolam—Dry mouth—Ezetimibe—atherosclerosis	0.000748	0.00368	CcSEcCtD
Triazolam—Muscle spasms—Pravastatin—atherosclerosis	0.000745	0.00367	CcSEcCtD
Triazolam—Confusional state—Ezetimibe—atherosclerosis	0.000739	0.00364	CcSEcCtD
Triazolam—Chest pain—Simvastatin—atherosclerosis	0.000729	0.00359	CcSEcCtD
Triazolam—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000727	0.00358	CcSEcCtD
Triazolam—Anxiety—Simvastatin—atherosclerosis	0.000727	0.00358	CcSEcCtD
Triazolam—Tremor—Pravastatin—atherosclerosis	0.000726	0.00357	CcSEcCtD
Triazolam—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000721	0.00355	CcSEcCtD
Triazolam—Discomfort—Simvastatin—atherosclerosis	0.000721	0.00355	CcSEcCtD
Triazolam—Ill-defined disorder—Pravastatin—atherosclerosis	0.000719	0.00354	CcSEcCtD
Triazolam—Anorexia—Lovastatin—atherosclerosis	0.000713	0.00351	CcSEcCtD
Triazolam—Syncope—Niacin—atherosclerosis	0.000706	0.00347	CcSEcCtD
Triazolam—Confusional state—Simvastatin—atherosclerosis	0.000705	0.00347	CcSEcCtD
Triazolam—Oedema—Simvastatin—atherosclerosis	0.000699	0.00344	CcSEcCtD
Triazolam—Malaise—Pravastatin—atherosclerosis	0.000699	0.00344	CcSEcCtD
Triazolam—Abdominal pain—Rosuvastatin—atherosclerosis	0.000697	0.00343	CcSEcCtD
Triazolam—Palpitations—Niacin—atherosclerosis	0.000695	0.00342	CcSEcCtD
Triazolam—Loss of consciousness—Niacin—atherosclerosis	0.000691	0.0034	CcSEcCtD
Triazolam—Insomnia—Lovastatin—atherosclerosis	0.000676	0.00333	CcSEcCtD
Triazolam—Paraesthesia—Lovastatin—atherosclerosis	0.000671	0.0033	CcSEcCtD
Triazolam—Hypertension—Pravastatin—atherosclerosis	0.000669	0.00329	CcSEcCtD
Triazolam—Anorexia—Simvastatin—atherosclerosis	0.000667	0.00328	CcSEcCtD
Triazolam—Dyspnoea—Lovastatin—atherosclerosis	0.000667	0.00328	CcSEcCtD
Triazolam—Insomnia—Ezetimibe—atherosclerosis	0.000663	0.00326	CcSEcCtD
Triazolam—Chest pain—Pravastatin—atherosclerosis	0.000659	0.00325	CcSEcCtD
Triazolam—Paraesthesia—Ezetimibe—atherosclerosis	0.000658	0.00324	CcSEcCtD
Triazolam—Anxiety—Pravastatin—atherosclerosis	0.000657	0.00323	CcSEcCtD
Triazolam—Dry mouth—Niacin—atherosclerosis	0.000655	0.00322	CcSEcCtD
Triazolam—Dyspnoea—Ezetimibe—atherosclerosis	0.000654	0.00322	CcSEcCtD
Triazolam—Discomfort—Pravastatin—atherosclerosis	0.000652	0.00321	CcSEcCtD
Triazolam—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00065	0.0032	CcSEcCtD
Triazolam—Decreased appetite—Lovastatin—atherosclerosis	0.00065	0.0032	CcSEcCtD
Triazolam—Fatigue—Lovastatin—atherosclerosis	0.000645	0.00317	CcSEcCtD
Triazolam—Oedema—Niacin—atherosclerosis	0.000642	0.00316	CcSEcCtD
Triazolam—Pain—Lovastatin—atherosclerosis	0.000639	0.00315	CcSEcCtD
Triazolam—Constipation—Lovastatin—atherosclerosis	0.000639	0.00315	CcSEcCtD
Triazolam—Confusional state—Pravastatin—atherosclerosis	0.000637	0.00314	CcSEcCtD
Triazolam—Decreased appetite—Ezetimibe—atherosclerosis	0.000637	0.00314	CcSEcCtD
Triazolam—Asthenia—Rosuvastatin—atherosclerosis	0.000633	0.00312	CcSEcCtD
Triazolam—Insomnia—Simvastatin—atherosclerosis	0.000632	0.00311	CcSEcCtD
Triazolam—Oedema—Pravastatin—atherosclerosis	0.000632	0.00311	CcSEcCtD
Triazolam—Fatigue—Ezetimibe—atherosclerosis	0.000632	0.00311	CcSEcCtD
Triazolam—Shock—Niacin—atherosclerosis	0.000632	0.00311	CcSEcCtD
Triazolam—Paraesthesia—Simvastatin—atherosclerosis	0.000628	0.00309	CcSEcCtD
Triazolam—Pain—Ezetimibe—atherosclerosis	0.000627	0.00309	CcSEcCtD
Triazolam—Constipation—Ezetimibe—atherosclerosis	0.000627	0.00309	CcSEcCtD
Triazolam—Tachycardia—Niacin—atherosclerosis	0.000627	0.00308	CcSEcCtD
Triazolam—Pruritus—Rosuvastatin—atherosclerosis	0.000624	0.00307	CcSEcCtD
Triazolam—Dyspnoea—Simvastatin—atherosclerosis	0.000623	0.00307	CcSEcCtD
Triazolam—Hyperhidrosis—Niacin—atherosclerosis	0.000621	0.00305	CcSEcCtD
Triazolam—Feeling abnormal—Lovastatin—atherosclerosis	0.000616	0.00303	CcSEcCtD
Triazolam—Anorexia—Niacin—atherosclerosis	0.000612	0.00301	CcSEcCtD
Triazolam—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000611	0.00301	CcSEcCtD
Triazolam—Hyperhidrosis—Pravastatin—atherosclerosis	0.000611	0.00301	CcSEcCtD
Triazolam—Decreased appetite—Simvastatin—atherosclerosis	0.000608	0.00299	CcSEcCtD
Triazolam—Feeling abnormal—Ezetimibe—atherosclerosis	0.000604	0.00297	CcSEcCtD
Triazolam—Diarrhoea—Rosuvastatin—atherosclerosis	0.000604	0.00297	CcSEcCtD
Triazolam—Fatigue—Simvastatin—atherosclerosis	0.000603	0.00297	CcSEcCtD
Triazolam—Anorexia—Pravastatin—atherosclerosis	0.000603	0.00297	CcSEcCtD
Triazolam—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0006	0.00295	CcSEcCtD
Triazolam—Constipation—Simvastatin—atherosclerosis	0.000598	0.00294	CcSEcCtD
Triazolam—Pain—Simvastatin—atherosclerosis	0.000598	0.00294	CcSEcCtD
Triazolam—Abdominal pain—Lovastatin—atherosclerosis	0.000591	0.00291	CcSEcCtD
Triazolam—Dizziness—Rosuvastatin—atherosclerosis	0.000583	0.00287	CcSEcCtD
Triazolam—Insomnia—Niacin—atherosclerosis	0.000581	0.00286	CcSEcCtD
Triazolam—Abdominal pain—Ezetimibe—atherosclerosis	0.00058	0.00285	CcSEcCtD
Triazolam—Paraesthesia—Niacin—atherosclerosis	0.000577	0.00284	CcSEcCtD
Triazolam—Feeling abnormal—Simvastatin—atherosclerosis	0.000576	0.00284	CcSEcCtD
Triazolam—Dyspnoea—Niacin—atherosclerosis	0.000572	0.00282	CcSEcCtD
Triazolam—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000572	0.00281	CcSEcCtD
Triazolam—Insomnia—Pravastatin—atherosclerosis	0.000572	0.00281	CcSEcCtD
Triazolam—Somnolence—Niacin—atherosclerosis	0.000571	0.00281	CcSEcCtD
Triazolam—Paraesthesia—Pravastatin—atherosclerosis	0.000568	0.00279	CcSEcCtD
Triazolam—Dyspnoea—Pravastatin—atherosclerosis	0.000564	0.00277	CcSEcCtD
Triazolam—Decreased appetite—Niacin—atherosclerosis	0.000558	0.00275	CcSEcCtD
Triazolam—Dermatitis—Rosuvastatin—atherosclerosis	0.000556	0.00273	CcSEcCtD
Triazolam—Abdominal pain—Simvastatin—atherosclerosis	0.000553	0.00272	CcSEcCtD
Triazolam—Headache—Rosuvastatin—atherosclerosis	0.000553	0.00272	CcSEcCtD
Triazolam—Hypersensitivity—Lovastatin—atherosclerosis	0.000551	0.00271	CcSEcCtD
Triazolam—Decreased appetite—Pravastatin—atherosclerosis	0.00055	0.0027	CcSEcCtD
Triazolam—Pain—Niacin—atherosclerosis	0.000549	0.0027	CcSEcCtD
Triazolam—Fatigue—Pravastatin—atherosclerosis	0.000545	0.00268	CcSEcCtD
Triazolam—Pain—Pravastatin—atherosclerosis	0.000541	0.00266	CcSEcCtD
Triazolam—Constipation—Pravastatin—atherosclerosis	0.000541	0.00266	CcSEcCtD
Triazolam—Hypersensitivity—Ezetimibe—atherosclerosis	0.00054	0.00266	CcSEcCtD
Triazolam—Asthenia—Lovastatin—atherosclerosis	0.000536	0.00264	CcSEcCtD
Triazolam—Pruritus—Lovastatin—atherosclerosis	0.000529	0.0026	CcSEcCtD
Triazolam—Asthenia—Ezetimibe—atherosclerosis	0.000526	0.00259	CcSEcCtD
Triazolam—Gastrointestinal pain—Niacin—atherosclerosis	0.000525	0.00258	CcSEcCtD
Triazolam—Nausea—Rosuvastatin—atherosclerosis	0.000524	0.00258	CcSEcCtD
Triazolam—Feeling abnormal—Pravastatin—atherosclerosis	0.000521	0.00256	CcSEcCtD
Triazolam—Pruritus—Ezetimibe—atherosclerosis	0.000519	0.00255	CcSEcCtD
Triazolam—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000517	0.00254	CcSEcCtD
Triazolam—Hypersensitivity—Simvastatin—atherosclerosis	0.000515	0.00254	CcSEcCtD
Triazolam—Diarrhoea—Lovastatin—atherosclerosis	0.000512	0.00252	CcSEcCtD
Triazolam—Abdominal pain—Niacin—atherosclerosis	0.000508	0.0025	CcSEcCtD
Triazolam—Asthenia—Simvastatin—atherosclerosis	0.000502	0.00247	CcSEcCtD
Triazolam—Diarrhoea—Ezetimibe—atherosclerosis	0.000502	0.00247	CcSEcCtD
Triazolam—Abdominal pain—Pravastatin—atherosclerosis	0.0005	0.00246	CcSEcCtD
Triazolam—Pruritus—Simvastatin—atherosclerosis	0.000495	0.00243	CcSEcCtD
Triazolam—Dizziness—Lovastatin—atherosclerosis	0.000494	0.00243	CcSEcCtD
Triazolam—Dizziness—Ezetimibe—atherosclerosis	0.000485	0.00239	CcSEcCtD
Triazolam—Diarrhoea—Simvastatin—atherosclerosis	0.000478	0.00235	CcSEcCtD
Triazolam—Vomiting—Lovastatin—atherosclerosis	0.000475	0.00234	CcSEcCtD
Triazolam—Hypersensitivity—Niacin—atherosclerosis	0.000473	0.00233	CcSEcCtD
Triazolam—Dermatitis—Lovastatin—atherosclerosis	0.000471	0.00232	CcSEcCtD
Triazolam—Headache—Lovastatin—atherosclerosis	0.000468	0.0023	CcSEcCtD
Triazolam—Vomiting—Ezetimibe—atherosclerosis	0.000466	0.00229	CcSEcCtD
Triazolam—Hypersensitivity—Pravastatin—atherosclerosis	0.000466	0.00229	CcSEcCtD
Triazolam—Dizziness—Simvastatin—atherosclerosis	0.000462	0.00228	CcSEcCtD
Triazolam—Dermatitis—Ezetimibe—atherosclerosis	0.000462	0.00227	CcSEcCtD
Triazolam—Asthenia—Niacin—atherosclerosis	0.000461	0.00227	CcSEcCtD
Triazolam—Headache—Ezetimibe—atherosclerosis	0.000459	0.00226	CcSEcCtD
Triazolam—Pruritus—Niacin—atherosclerosis	0.000454	0.00224	CcSEcCtD
Triazolam—Asthenia—Pravastatin—atherosclerosis	0.000454	0.00223	CcSEcCtD
Triazolam—Pruritus—Pravastatin—atherosclerosis	0.000447	0.0022	CcSEcCtD
Triazolam—Vomiting—Simvastatin—atherosclerosis	0.000445	0.00219	CcSEcCtD
Triazolam—Nausea—Lovastatin—atherosclerosis	0.000444	0.00219	CcSEcCtD
Triazolam—Dermatitis—Simvastatin—atherosclerosis	0.000441	0.00217	CcSEcCtD
Triazolam—Diarrhoea—Niacin—atherosclerosis	0.000439	0.00216	CcSEcCtD
Triazolam—Headache—Simvastatin—atherosclerosis	0.000438	0.00216	CcSEcCtD
Triazolam—Nausea—Ezetimibe—atherosclerosis	0.000436	0.00214	CcSEcCtD
Triazolam—Diarrhoea—Pravastatin—atherosclerosis	0.000433	0.00213	CcSEcCtD
Triazolam—Dizziness—Niacin—atherosclerosis	0.000425	0.00209	CcSEcCtD
Triazolam—Dizziness—Pravastatin—atherosclerosis	0.000418	0.00206	CcSEcCtD
Triazolam—Nausea—Simvastatin—atherosclerosis	0.000415	0.00204	CcSEcCtD
Triazolam—Vomiting—Niacin—atherosclerosis	0.000408	0.00201	CcSEcCtD
Triazolam—Dermatitis—Niacin—atherosclerosis	0.000404	0.00199	CcSEcCtD
Triazolam—Headache—Niacin—atherosclerosis	0.000402	0.00198	CcSEcCtD
Triazolam—Vomiting—Pravastatin—atherosclerosis	0.000402	0.00198	CcSEcCtD
Triazolam—Dermatitis—Pravastatin—atherosclerosis	0.000398	0.00196	CcSEcCtD
Triazolam—Headache—Pravastatin—atherosclerosis	0.000396	0.00195	CcSEcCtD
Triazolam—Nausea—Niacin—atherosclerosis	0.000381	0.00188	CcSEcCtD
Triazolam—Nausea—Pravastatin—atherosclerosis	0.000376	0.00185	CcSEcCtD
Triazolam—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.99e-05	0.000375	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCG1—atherosclerosis	1.99e-05	0.000373	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.94e-05	0.000365	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.92e-05	0.000362	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PLA2G1B—atherosclerosis	1.92e-05	0.000361	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.89e-05	0.000356	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.88e-05	0.000354	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ALB—atherosclerosis	1.87e-05	0.000352	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.87e-05	0.000352	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—FABP4—atherosclerosis	1.87e-05	0.000351	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LCAT—atherosclerosis	1.87e-05	0.000351	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALOX5—atherosclerosis	1.86e-05	0.000349	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ALB—atherosclerosis	1.84e-05	0.000345	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOA4—atherosclerosis	1.83e-05	0.000345	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.83e-05	0.000343	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.81e-05	0.00034	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.8e-05	0.000339	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP7A1—atherosclerosis	1.8e-05	0.000339	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ALB—atherosclerosis	1.79e-05	0.000337	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.77e-05	0.000333	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.77e-05	0.000333	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.76e-05	0.000331	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.75e-05	0.000329	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCG1—atherosclerosis	1.72e-05	0.000323	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NAMPT—atherosclerosis	1.66e-05	0.000313	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP27A1—atherosclerosis	1.66e-05	0.000313	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—LIPC—atherosclerosis	1.65e-05	0.000311	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.65e-05	0.000311	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOC3—atherosclerosis	1.64e-05	0.000309	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—LDLR—atherosclerosis	1.63e-05	0.000307	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—FABP4—atherosclerosis	1.62e-05	0.000304	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LCAT—atherosclerosis	1.62e-05	0.000304	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CETP—atherosclerosis	1.6e-05	0.0003	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOA4—atherosclerosis	1.59e-05	0.000299	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALOX15—atherosclerosis	1.58e-05	0.000297	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	1.58e-05	0.000297	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	1.58e-05	0.000297	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOA2—atherosclerosis	1.58e-05	0.000297	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP7A1—atherosclerosis	1.56e-05	0.000293	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCG5—atherosclerosis	1.56e-05	0.000293	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.54e-05	0.000289	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SCARB1—atherosclerosis	1.53e-05	0.000287	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LPA—atherosclerosis	1.51e-05	0.000283	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.49e-05	0.000279	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.47e-05	0.000277	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—BGN—atherosclerosis	1.46e-05	0.000274	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMGCR—atherosclerosis	1.44e-05	0.000271	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOA5—atherosclerosis	1.44e-05	0.000271	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP27A1—atherosclerosis	1.44e-05	0.000271	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.43e-05	0.000269	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.42e-05	0.000267	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.4e-05	0.000263	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1.39e-05	0.000261	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.38e-05	0.00026	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	1.37e-05	0.000257	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOA2—atherosclerosis	1.37e-05	0.000257	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALOX15—atherosclerosis	1.37e-05	0.000257	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	1.37e-05	0.000257	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.35e-05	0.000254	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.35e-05	0.000254	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLTP—atherosclerosis	1.35e-05	0.000253	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.34e-05	0.000252	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—FABP4—atherosclerosis	1.32e-05	0.000248	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LCAT—atherosclerosis	1.32e-05	0.000248	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LPA—atherosclerosis	1.3e-05	0.000245	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA4—atherosclerosis	1.29e-05	0.000243	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCA1—atherosclerosis	1.29e-05	0.000242	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.27e-05	0.000239	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—BGN—atherosclerosis	1.26e-05	0.000237	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.25e-05	0.000236	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOA5—atherosclerosis	1.25e-05	0.000235	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.21e-05	0.000228	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.21e-05	0.000227	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.2e-05	0.000226	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.2e-05	0.000226	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LIPC—atherosclerosis	1.2e-05	0.000225	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.19e-05	0.000224	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOC3—atherosclerosis	1.19e-05	0.000223	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LDLR—atherosclerosis	1.18e-05	0.000222	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.18e-05	0.000222	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.18e-05	0.000221	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.17e-05	0.000221	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.17e-05	0.00022	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.17e-05	0.00022	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.16e-05	0.000219	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.16e-05	0.000217	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CETP—atherosclerosis	1.15e-05	0.000217	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.13e-05	0.000212	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.11e-05	0.000209	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.11e-05	0.000209	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.11e-05	0.000209	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA2—atherosclerosis	1.11e-05	0.000209	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.1e-05	0.000208	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.1e-05	0.000208	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.1e-05	0.000207	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.1e-05	0.000206	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.07e-05	0.000202	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LPA—atherosclerosis	1.06e-05	0.0002	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOB—atherosclerosis	1.06e-05	0.000199	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.04e-05	0.000196	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NAMPT—atherosclerosis	1.04e-05	0.000196	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.04e-05	0.000195	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LIPC—atherosclerosis	1.04e-05	0.000195	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOC3—atherosclerosis	1.03e-05	0.000194	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.03e-05	0.000193	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—BGN—atherosclerosis	1.03e-05	0.000193	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LDLR—atherosclerosis	1.02e-05	0.000192	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.02e-05	0.000192	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA5—atherosclerosis	1.02e-05	0.000191	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—LPL—atherosclerosis	1.01e-05	0.00019	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CETP—atherosclerosis	9.99e-06	0.000188	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.88e-06	0.000186	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GPX1—atherosclerosis	9.85e-06	0.000185	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	9.79e-06	0.000184	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.68e-06	0.000182	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.59e-06	0.00018	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CD36—atherosclerosis	9.59e-06	0.00018	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.57e-06	0.00018	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SCARB1—atherosclerosis	9.57e-06	0.00018	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALOX5—atherosclerosis	9.46e-06	0.000178	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	9.32e-06	0.000175	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCA1—atherosclerosis	9.3e-06	0.000175	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.23e-06	0.000174	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—atherosclerosis	9.09e-06	0.000171	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMGCR—atherosclerosis	9.04e-06	0.00017	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARA—atherosclerosis	8.92e-06	0.000168	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.74e-06	0.000164	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FABP4—atherosclerosis	8.68e-06	0.000163	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LCAT—atherosclerosis	8.68e-06	0.000163	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AGT—atherosclerosis	8.64e-06	0.000162	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA4—atherosclerosis	8.52e-06	0.00016	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.48e-06	0.00016	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOE—atherosclerosis	8.46e-06	0.000159	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.43e-06	0.000159	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LIPC—atherosclerosis	8.43e-06	0.000159	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAV1—atherosclerosis	8.38e-06	0.000158	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOC3—atherosclerosis	8.38e-06	0.000158	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.37e-06	0.000157	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOA1—atherosclerosis	8.37e-06	0.000157	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LDLR—atherosclerosis	8.33e-06	0.000157	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.15e-06	0.000153	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CETP—atherosclerosis	8.13e-06	0.000153	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCA1—atherosclerosis	8.05e-06	0.000151	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—atherosclerosis	7.98e-06	0.00015	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.79e-06	0.000146	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.74e-06	0.000146	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOB—atherosclerosis	7.64e-06	0.000144	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CG—atherosclerosis	7.64e-06	0.000144	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.58e-06	0.000143	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—atherosclerosis	7.43e-06	0.00014	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARG—atherosclerosis	7.37e-06	0.000139	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.36e-06	0.000138	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA2—atherosclerosis	7.34e-06	0.000138	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.34e-06	0.000138	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.34e-06	0.000138	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.34e-06	0.000138	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LPL—atherosclerosis	7.3e-06	0.000137	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.25e-06	0.000136	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—INS—atherosclerosis	7.23e-06	0.000136	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GPX1—atherosclerosis	7.12e-06	0.000134	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LPA—atherosclerosis	7e-06	0.000132	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CD36—atherosclerosis	6.93e-06	0.00013	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—atherosclerosis	6.91e-06	0.00013	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—BGN—atherosclerosis	6.78e-06	0.000127	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA5—atherosclerosis	6.71e-06	0.000126	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.63e-06	0.000125	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—atherosclerosis	6.63e-06	0.000125	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOB—atherosclerosis	6.62e-06	0.000124	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—atherosclerosis	6.57e-06	0.000124	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.56e-06	0.000123	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.46e-06	0.000121	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARA—atherosclerosis	6.45e-06	0.000121	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—atherosclerosis	6.44e-06	0.000121	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—atherosclerosis	6.34e-06	0.000119	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LPL—atherosclerosis	6.32e-06	0.000119	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AGT—atherosclerosis	6.24e-06	0.000117	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.24e-06	0.000117	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GPX1—atherosclerosis	6.17e-06	0.000116	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOE—atherosclerosis	6.12e-06	0.000115	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAV1—atherosclerosis	6.06e-06	0.000114	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOA1—atherosclerosis	6.05e-06	0.000114	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CD36—atherosclerosis	6.01e-06	0.000113	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—atherosclerosis	5.8e-06	0.000109	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—atherosclerosis	5.69e-06	0.000107	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.62e-06	0.000106	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.59e-06	0.000105	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARA—atherosclerosis	5.58e-06	0.000105	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LIPC—atherosclerosis	5.56e-06	0.000105	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOC3—atherosclerosis	5.53e-06	0.000104	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CG—atherosclerosis	5.52e-06	0.000104	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LDLR—atherosclerosis	5.49e-06	0.000103	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AGT—atherosclerosis	5.41e-06	0.000102	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOB—atherosclerosis	5.39e-06	0.000101	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CETP—atherosclerosis	5.36e-06	0.000101	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARG—atherosclerosis	5.33e-06	0.0001	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOE—atherosclerosis	5.3e-06	9.96e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAV1—atherosclerosis	5.25e-06	9.87e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.24e-06	9.85e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOA1—atherosclerosis	5.24e-06	9.85e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—INS—atherosclerosis	5.23e-06	9.83e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LPL—atherosclerosis	5.14e-06	9.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.14e-06	9.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPX1—atherosclerosis	5.02e-06	9.44e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CD36—atherosclerosis	4.89e-06	9.19e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.85e-06	9.12e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—atherosclerosis	4.79e-06	9.01e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CG—atherosclerosis	4.78e-06	8.99e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.63e-06	8.71e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARG—atherosclerosis	4.61e-06	8.68e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—atherosclerosis	4.58e-06	8.62e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARA—atherosclerosis	4.54e-06	8.54e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—INS—atherosclerosis	4.53e-06	8.51e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AGT—atherosclerosis	4.4e-06	8.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.32e-06	8.13e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOE—atherosclerosis	4.31e-06	8.11e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAV1—atherosclerosis	4.27e-06	8.03e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOA1—atherosclerosis	4.26e-06	8.02e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.19e-06	7.88e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—atherosclerosis	4.15e-06	7.8e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—atherosclerosis	3.97e-06	7.46e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.89e-06	7.32e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARG—atherosclerosis	3.76e-06	7.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.71e-06	6.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—INS—atherosclerosis	3.68e-06	6.93e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.63e-06	6.83e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOB—atherosclerosis	3.55e-06	6.68e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.46e-06	6.5e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LPL—atherosclerosis	3.39e-06	6.38e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—atherosclerosis	3.38e-06	6.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX1—atherosclerosis	3.31e-06	6.22e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—atherosclerosis	3.23e-06	6.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CD36—atherosclerosis	3.22e-06	6.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.05e-06	5.74e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARA—atherosclerosis	3e-06	5.63e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.95e-06	5.56e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—atherosclerosis	2.91e-06	5.48e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AGT—atherosclerosis	2.9e-06	5.46e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOE—atherosclerosis	2.84e-06	5.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAV1—atherosclerosis	2.82e-06	5.3e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOA1—atherosclerosis	2.81e-06	5.29e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.57e-06	4.83e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARG—atherosclerosis	2.48e-06	4.66e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—INS—atherosclerosis	2.43e-06	4.57e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—atherosclerosis	2.23e-06	4.19e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—atherosclerosis	2.13e-06	4.01e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—atherosclerosis	2.11e-06	3.96e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.95e-06	3.66e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—atherosclerosis	1.82e-06	3.43e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—atherosclerosis	1.48e-06	2.79e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—atherosclerosis	9.79e-07	1.84e-05	CbGpPWpGaD
